CN85103913A - 胶原酶制备工艺 - Google Patents
胶原酶制备工艺 Download PDFInfo
- Publication number
- CN85103913A CN85103913A CN 85103913 CN85103913A CN85103913A CN 85103913 A CN85103913 A CN 85103913A CN 85103913 CN85103913 CN 85103913 CN 85103913 A CN85103913 A CN 85103913A CN 85103913 A CN85103913 A CN 85103913A
- Authority
- CN
- China
- Prior art keywords
- collagenase
- fermented liquid
- desalination
- obtains
- damping fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000029816 Collagenase Human genes 0.000 title claims abstract description 30
- 108060005980 Collagenase Proteins 0.000 title claims abstract description 30
- 229960002424 collagenase Drugs 0.000 title claims abstract description 30
- 238000005516 engineering process Methods 0.000 title claims description 5
- 239000007788 liquid Substances 0.000 claims abstract description 12
- 238000000855 fermentation Methods 0.000 claims abstract description 7
- 230000004151 fermentation Effects 0.000 claims abstract description 7
- 239000012043 crude product Substances 0.000 claims abstract description 5
- 238000010612 desalination reaction Methods 0.000 claims abstract description 5
- 238000011146 sterile filtration Methods 0.000 claims abstract description 5
- 238000012870 ammonium sulfate precipitation Methods 0.000 claims abstract description 4
- 230000003068 static effect Effects 0.000 claims abstract description 4
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims abstract description 3
- 241000193403 Clostridium Species 0.000 claims abstract description 3
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 5
- 108010080698 Peptones Proteins 0.000 claims description 5
- 229940041514 candida albicans extract Drugs 0.000 claims description 5
- 238000013016 damping Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 235000013372 meat Nutrition 0.000 claims description 5
- 235000019319 peptone Nutrition 0.000 claims description 5
- 239000012138 yeast extract Substances 0.000 claims description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 8
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- 229940088598 enzyme Drugs 0.000 abstract description 7
- 238000002347 injection Methods 0.000 abstract description 4
- 239000007924 injection Substances 0.000 abstract description 4
- 238000009472 formulation Methods 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 108091005804 Peptidases Proteins 0.000 abstract description 2
- 239000004365 Protease Substances 0.000 abstract description 2
- 229920005654 Sephadex Polymers 0.000 abstract description 2
- 239000012507 Sephadex™ Substances 0.000 abstract description 2
- 230000001413 cellular effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 230000007062 hydrolysis Effects 0.000 abstract description 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract description 2
- 239000002674 ointment Substances 0.000 abstract description 2
- 238000005204 segregation Methods 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 238000004108 freeze drying Methods 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 238000004440 column chromatography Methods 0.000 abstract 1
- 229920001206 natural gum Polymers 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 241000590020 Achromobacter Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000193159 Hathewaya histolytica Species 0.000 description 1
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 241000607632 Vibrio alginolyticus chemovar iophagus Species 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000003453 ammonium sulfate precipitation method Methods 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明属于酶工程或生物工程的技术领域。胶原酶是一种在生理pH及温度条件下水解天然胶原酶的水解蛋白酶,我们将组织梭菌Cl·histolyticum64008经改进的培养基、发酵液静止发酵得到毒性低的胶原酶,将发酵液经过无菌过滤,硫酸铵沉淀、脱盐、冻干获得胶原酶粗品,再经DEAE柱层析及Sephadex G-25脱盐,冻干后可得精品,该胶原酶是细胞分离的重要工具酶,其油膏制剂用于治疗清疮脱痂,其注射用于治疗椎脊盘突出症
Description
本发明属酶工程或生物工程技术领域。
胶原酶(Collagenase)是一种在生理PH及温度条件下水解天然胶原蛋白酶,胶原酶不仅是细胞分离的重要工具酶,而且是外用清疮脱痂,局部注射治疗椎脊盘突出症的良好药物。
1927年Ssadilow首先使用了“Collagenase”的名称,1938年Grassmenn第一次证明胶原酶的存在,它能作用于天然胶原分子的特异性螺旋体结构部份,通过对各种菌产生胶原酶的研究,认为只有溶组织梭状芽孢杆菌(Clostridum histolyticum)与介毒无色杆菌(Achro-mobacter iophagus)较有价值,在胶原酶的制备方面,美国哥伦比亚大学I.mandl博士提出的发酵配方提取方法及检定方法至今仍为各国研究工作者采用。五十年代提纯胶原酶的方法有四类:(1)硫酸铵沉淀法(2)有机溶剂沉淀分离法,(3)电泳法(4)吸附洗脱法。1959年,Grant.N.H.Alburn,H.z报导使用DEAE离子交换层析精制胶原酶的方法,七十年代至今采用的方法主要有两类:(一)利用各种交换材料及分子筛进一步分离提纯胶原酶(二)用亲和层析提纯胶原酶。
原工艺路线长,发酵液配方复杂。
本发明为了提高胶原酶的质量,改进了发酵液配方,改进了提取精制方法,提高收率。
本发明制备工艺为:
1.菌种Cl.histolyticum 64008。
2.培养基配方:酵母膏0.2-1%,酵母粉0.2-1%,明胶1%-3%,肉胨2%-6%。
3.发酵液培养温度:37℃-42℃,周期为40-45小时,静止发酵。
4.发酵液经无菌过滤后,在10℃以下,加硫酸铵沉淀胶原酶,使浓度达到45-55%(重量/体积)所获沉淀溶于PH7-8,Tris-Ca++缓冲液在低温与氮气加压下经超滤膜脱盐,冷冻干燥获胶原酶粗品。
5.胶原酶粗品经以PH5-6,HAC-NaAC缓冲液平衡之DEAE纤维素柱层析,下柱液再经PH6.0-7.5电导水平衡的SephadexG-25柱,获得溶液经冰冷干燥即为胶原酶精制品,活力达到800-1000单位/毫克蛋白质。
实施例1、
菌种组织梭菌Cl.histolyticum64008
一级种液:酵母膏0.2%-1.0%,牛肉膏1%-2%,肉胨2%-6%,明胶1%-3%;二级种液:酵母膏0.2%-1.0%肉胨2%-6%,明胶1%-3%;接种量3%-5%,培养温度37℃-42℃,周期24小时,发酵液:酵母膏0.2%-1%,酵母粉0.2%-1%,明胶1%-3%,肉胨2%-6%,PH7-8,温度37℃-42℃,周期40-45小时,静止发酵,发酵液效价在400单位/毫克,毒性安全剂量小白鼠尾静脉注射50单位/只。发酵液经无菌过滤,泵压至盐水冷却锅,在低温下加入硫酸铵使达50%浓度(重量/体积),再加入1%氯化钙,放置过夜,收集硫酸铵沉淀,溶解于0.05克分子/Tris-Ca++缓冲液,离心除杂质收集粗酶液,以超滤膜脱盐,无菌过滤,冷冻干燥,得胶原酶粗品,较发酵液的比活力提高5-10倍,酶活性收率为50%。
例2:
以PH5-6的醋酸缓冲液平衡DEAE-Cellulose装柱3.6×50厘米柱,进样量控制在30万-50万单位,粗酶溶于醋酸缓冲液,上柱,收集胶原酶部份,再上Sephadex G-25柱(3.6×50厘米),以NaCL,NaoH调节水使电导达40-70微欧-1,收集胶原酶部份,冷冰干燥,所获得胶原酶精品纯度可达800-1000单位/毫克蛋白质,每1200胶原酶单位中,蛋白酶含量低于10单位。
按本工艺制得的胶原酶,产品质量符合要求,制备的胶原酶试剂可供各研究单位分离细胞用,制备药理规格的外用油膏制剂可用于治疗清疮脱痂,制备的注射剂可用于治疗椎脊盘突出症。
Claims (1)
1、一种利用组织梭菌Cl,histolgticum64008经培养发酵后再经DEAE纤维素及分子筛分离提纯胶原酶的工艺,本发明的特征在于将菌种经组份为酵母膏0.2-1%,酵母粉0.2-1%,明胶1-3%,肉胨2-6%的培养基在温度为37-42℃,周期40-45小时静止发酵后,无菌过滤,在10℃以下加硫酸铵沉淀胶原酶,使浓度达到45-55%(重量/体积),所获沉淀溶于PH7-8Tris-Ca++缓冲液在低温与氮气加压下经招滤膜脱盐,冷冻干燥获胶原酶粗品,然后经以PH5-6,HAC-NaAc缓冲液平衡之DEAE纤维素柱层析,下柱液再经PH6.0-7.5电导水平衡的SephadexG-25粒,得到溶液经冷冻干燥即为胶原酶精品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 85103913 CN85103913A (zh) | 1985-06-19 | 1985-06-19 | 胶原酶制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 85103913 CN85103913A (zh) | 1985-06-19 | 1985-06-19 | 胶原酶制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN85103913A true CN85103913A (zh) | 1986-12-24 |
Family
ID=4793521
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 85103913 Pending CN85103913A (zh) | 1985-06-19 | 1985-06-19 | 胶原酶制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN85103913A (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058750C (zh) * | 1992-03-03 | 2000-11-22 | 山西医科大学 | 一种从双胸蚓中提取胶原酶的方法 |
CN101870965A (zh) * | 2010-06-01 | 2010-10-27 | 青岛康地恩生物科技有限公司 | 一种高酶活速溶酶制剂的生产方法 |
CN103320361A (zh) * | 2013-06-27 | 2013-09-25 | 山东大学 | 一株产酸的梭菌及其在造纸废水处理中的应用 |
CN101534920B (zh) * | 2006-11-01 | 2013-10-16 | 比奥根艾迪克Ma公司 | 通过低ph和二价阳离子分离生物大分子的方法 |
CN104508127A (zh) * | 2012-04-18 | 2015-04-08 | 菲迪亚制药股份公司 | 用于产生和纯化来自溶藻弧菌(Vibrio alginolyticus)的胶原酶的新方法 |
-
1985
- 1985-06-19 CN CN 85103913 patent/CN85103913A/zh active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1058750C (zh) * | 1992-03-03 | 2000-11-22 | 山西医科大学 | 一种从双胸蚓中提取胶原酶的方法 |
CN101534920B (zh) * | 2006-11-01 | 2013-10-16 | 比奥根艾迪克Ma公司 | 通过低ph和二价阳离子分离生物大分子的方法 |
CN101870965A (zh) * | 2010-06-01 | 2010-10-27 | 青岛康地恩生物科技有限公司 | 一种高酶活速溶酶制剂的生产方法 |
CN104508127A (zh) * | 2012-04-18 | 2015-04-08 | 菲迪亚制药股份公司 | 用于产生和纯化来自溶藻弧菌(Vibrio alginolyticus)的胶原酶的新方法 |
CN103320361A (zh) * | 2013-06-27 | 2013-09-25 | 山东大学 | 一株产酸的梭菌及其在造纸废水处理中的应用 |
CN103320361B (zh) * | 2013-06-27 | 2015-05-13 | 山东大学 | 一株产酸的梭菌及其在造纸废水处理中的应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101297821B (zh) | 桑黄菌丝体活性糖蛋白及其用途和制备方法 | |
CN111909284B (zh) | 一种茶麸多糖的提取纯化方法及含茶麸多糖的头皮护理组合物 | |
CN110507681A (zh) | 一种高值化利用人参花的工艺 | |
CN85103913A (zh) | 胶原酶制备工艺 | |
CN101962637B (zh) | 一种蛹虫草纤溶酶及其培制方法 | |
EP0067697B1 (en) | Cell culture method | |
CN116497077A (zh) | 一种利用银耳提取液制备嗜热栖热菌发酵产物的方法 | |
CN101629167B (zh) | 一种提取超氧化物歧化酶的方法 | |
CN103864954A (zh) | 一种花生粕多糖的提取方法 | |
CN103589706B (zh) | 纳豆激酶的提纯方法及制备方法 | |
CN117186183B (zh) | 一种人参来源的活性肽及其制备方法和肠道损伤保护的应用 | |
CN110642958B (zh) | 一种桑黄多糖的提取方法及应用 | |
Thuy et al. | Deproteinization in purification of exopolysaccharide from Ophiocordyceps sinensis olive oil-stimulated culture. | |
CN1087817A (zh) | 蚯蚓组分提取方法 | |
CN1058293C (zh) | 中药酶法提取 | |
CN1101224C (zh) | 一种戒心瘾注射液 | |
CN107011464A (zh) | 一种高效的粗品肝素钠生产工艺 | |
CN1546644A (zh) | 冬虫夏草菌粉与活性免疫虫草多糖冻干粉的生产方法及产品 | |
DE69230887T2 (de) | Escharase enthaltene proteolytische mischung und methode seiner isolierung | |
CN114276468B (zh) | 一种天然成分和在美白并增加皮肤弹性中的应用 | |
RU2201962C2 (ru) | Способ получения рекомбинантного гранулоцитарного колониестимулирующего фактора человека | |
CN107418945A (zh) | 一种厚垣镰孢霉分离纯化获得β‑葡萄糖苷酶的方法 | |
CN100392076C (zh) | 一种超氧化物歧化酶提取修饰方法 | |
CN118105456A (zh) | 一种文冠果小分子肽修复组合物及其制备方法 | |
CN1287167A (zh) | 营养酸模sod的提取工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |